
Journal of Heterocyclic Chemistry p. 649 - 652 (1997)
Update date:2022-08-05
Topics:
Moniz, George A.
Hammond, Gerald B.
Aminoglutethimide [3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione] has been used clinically in the treatment of metastatic breast carcinoma. Inhibition of tumor growth is due to interference with estrogen biosynthesis. However, its action is not specific and its metabolism gives rise to toxic and non-inhibitory metabolites. We sought to explore the impact of relocating the amino group in aminoglutethimide to the ethyl side chain. To that end, we now report the synthesis and aromatase-inhibitory activity of 3-(2′-N,N-diethylamino)ethyl-3-phenylpiperidine-2,6-dione 5. The introduction of the amino functionality on the ethyl group is accomplished via reductive amination of aldehyde 8, prepared in three steps from benzyl cyanide, The synthetic route presented can be used for the preparation of related derivatives of azninoglutethimide.
View MoreJiaozuo Zhongwen Trading Coporation Limited
Contact:--
Address:East Renmin Road
ALPHA PHARMACEUTICAL CO,LTD JIANGSU
Contact:+86-527-84829968,+86-527-84829998
Address:suqian city
Contact:021-36356756
Address:Room601,Building No.14,280 Yangcheng Road,Shanghai
website:http://www.lonwinchem.com
Contact:Tel: 86-21-59858395
Address:No#966,Huaxu Road,Shanghai 201702,P.R.China
Shanghai Science Peptide Biological Technology Co.,ltd
website:http://www.scipeptide.com
Contact:+86-21-51099675
Address:No.8 Changyang Rd
Doi:10.1021/jm960850i
(1997)Doi:10.1016/S0960-894X(97)00245-X
(1997)Doi:10.1021/jo01258a049
(1969)Doi:10.1002/hlca.19970800304
(1997)Doi:10.1016/S0040-4039(97)00777-6
(1997)Doi:10.1139/v68-306
(1968)